As of 2021, around 41 percent of all Canadians aged 18 years and older stated that they approved of medical use of psilocybin-assisted psychotherapy for treating post-traumatic stress disorders. This statistic illustrates the percentage of Canadian adults who approved of the medical use of psilocybin-assisted psychotherapy to treat post-traumatic stress disorders in 2021.
Percentage of Canadian adults who approved of allowing psilocybin-assisted psychotherapy to be used to medically treat post-traumatic stress disorders in 2021
Original question: "Do you approve, somewhat approve, somewhat disapprove or disapprove Q of the following uses for mushroom-based psilocybin-assisted therapy: Allowing the controlled medical use of mushroom-based psilocybin-assisted psychotherapy for Post-Traumatic Stress Disorders (PTSD)."
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Canadian Psychedelic Association. (August 4, 2021). Percentage of Canadian adults who approved of allowing psilocybin-assisted psychotherapy to be used to medically treat post-traumatic stress disorders in 2021 [Graph]. In Statista. Retrieved August 24, 2024, from https://www.statista.com/statistics/1256970/share-of-canadians-who-approve-of-psilocybin-assisted-psychotherapy-for-ptsd/
Canadian Psychedelic Association. "Percentage of Canadian adults who approved of allowing psilocybin-assisted psychotherapy to be used to medically treat post-traumatic stress disorders in 2021." Chart. August 4, 2021. Statista. Accessed August 24, 2024. https://www.statista.com/statistics/1256970/share-of-canadians-who-approve-of-psilocybin-assisted-psychotherapy-for-ptsd/
Canadian Psychedelic Association. (2021). Percentage of Canadian adults who approved of allowing psilocybin-assisted psychotherapy to be used to medically treat post-traumatic stress disorders in 2021. Statista. Statista Inc.. Accessed: August 24, 2024. https://www.statista.com/statistics/1256970/share-of-canadians-who-approve-of-psilocybin-assisted-psychotherapy-for-ptsd/
Canadian Psychedelic Association. "Percentage of Canadian Adults Who Approved of Allowing Psilocybin-assisted Psychotherapy to Be Used to Medically Treat Post-traumatic Stress Disorders in 2021." Statista, Statista Inc., 4 Aug 2021, https://www.statista.com/statistics/1256970/share-of-canadians-who-approve-of-psilocybin-assisted-psychotherapy-for-ptsd/
Canadian Psychedelic Association, Percentage of Canadian adults who approved of allowing psilocybin-assisted psychotherapy to be used to medically treat post-traumatic stress disorders in 2021 Statista, https://www.statista.com/statistics/1256970/share-of-canadians-who-approve-of-psilocybin-assisted-psychotherapy-for-ptsd/ (last visited August 24, 2024)
Percentage of Canadian adults who approved of allowing psilocybin-assisted psychotherapy to be used to medically treat post-traumatic stress disorders in 2021 [Graph], Canadian Psychedelic Association, August 4, 2021. [Online]. Available: https://www.statista.com/statistics/1256970/share-of-canadians-who-approve-of-psilocybin-assisted-psychotherapy-for-ptsd/
